Management of persistent ductus arteriosus in very premature neonates. Results of the French TRIOCAPI trial, perspectives for clinicians, and subsequent studies on this topic

Arch Pediatr. 2021 Oct;28(7):501-503. doi: 10.1016/j.arcped.2021.07.002. Epub 2021 Sep 9.

Authors

G Cambonie¹, Ronald I Clyman², J-C Rozé³

Affiliations

¹ Department of Neonatology, Montpellier University Hospital, 34295 Montpellier, France. Electronic address: g-cambonie@chu-montpellier.fr.
² Department of Pediatrics and Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA.
³ Department of Neonatology, Nantes University Hospital, 44000 Nantes, France.

PMID: 34511277
DOI: 10.1016/j.arcped.2021.07.002

No abstract available

Keywords: Echocardiography; Patent ductus arteriosus; Premature birth.

Publication types

Editorial

MeSH terms

Clinical Trials as Topic
Ductus Arteriosus*
Ductus Arteriosus, Patent* / drug therapy
Humans
Infant, Newborn
Infant, Premature